SSY Pharmaceutical Research Institute SSY Pharmaceutical Research Institute

Corporate email

中文/EN

简体中文

English

NEWS CENTER

Group Announcement

Media reports

Group News

Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas

Category:

Group News

Time：2022-06-22

Currently, Shijiazhuang No.4 Pharmaceutical is stepping up its efforts and racing against time to make a final “sprint,” striving to contribute to our city’s goal of exceeding one trillion yuan in economic output and achieving a pioneering breakthrough in the biopharmaceutical industry.
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas
Shijiazhuang Fourth Pharmaceutical Group: Going All Out to Achieve “Over Half” in Both Areas

Since the beginning of this year, Shijiazhuang Fourth Pharmaceutical Group has continuously stepped up its efforts in innovation and R&D, with innovative achievements steadily accelerating their transition into practical applications. As of now, the group has been granted registration certificates for 20 new products, placing it among the top in the nation’s pharmaceutical industry in terms of both the number and efficiency of its R&D projects.

Strong, resounding punches and distinctive products are helping enterprises “break new ground” in the market and continuously injecting new momentum into high-quality development. In the first five months of this year, sales revenue and profits and taxes both saw double-digit year-on-year growth, demonstrating tremendous market vitality and laying a solid foundation for achieving “more than half” of the annual targets.

Currently, Shijiazhuang No.4 Pharmaceutical is stepping up its efforts and racing against time to make a final “sprint,” striving to contribute to our city’s goal of exceeding one trillion yuan in economic output and achieving a pioneering breakthrough in the biopharmaceutical industry.

Keywords:

Previous

The grand ceremony marking the listing of Shijiazhuang Sihua Pharmaceutical Group Bosheng Medical Devices on the Innovation Board and the groundbreaking ceremony for the Biomembrane Workshop were held with great pomp and circumstance.

Dong Mingzhi, a member of the Standing Committee of the Cangzhou Municipal Party Committee, Secretary of the Party Working Committee of Bohai New Area, and Secretary of the Huanghua Municipal Party Committee, visited Guangxiang Pharmaceutical, a subsidiary of Shijiazhuang No. 4 Pharmaceutical Group, for research and inspection.

Next

Previous:

The grand ceremony marking the listing of Shijiazhuang Sihua Pharmaceutical Group Bosheng Medical Devices on the Innovation Board and the groundbreaking ceremony for the Biomembrane Workshop were held with great pomp and circumstance.

Next:

Dong Mingzhi, a member of the Standing Committee of the Cangzhou Municipal Party Committee, Secretary of the Party Working Committee of Bohai New Area, and Secretary of the Huanghua Municipal Party Committee, visited Guangxiang Pharmaceutical, a subsidiary of Shijiazhuang No. 4 Pharmaceutical Group, for research and inspection.